CAREDX, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
CAREDX, INC. (CDNA) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $1.58 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-07-30
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.58M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $4.11M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.58M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $3.20M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $1.58M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $4.11M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $1.58M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $3.20M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $4.71M 10-Q · filed 2025-04-30 |
| 2024-09-30 | $1.57M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $3.08M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $4.69M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $1.64M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $3.20M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.86M 10-Q · filed 2023-05-10 |
| 2022-09-30 | $1.51M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.09M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.69M 10-Q · filed 2022-05-05 |
| 2021-09-30 | $1.51M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $3.06M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $3.82M 10-Q · filed 2021-05-05 |
| 2020-09-30 | $1.23M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $2.41M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $3.39M 10-Q · filed 2020-04-30 |
| 2019-09-30 | $1.11M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $2.08M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $2.19M 10-Q · filed 2019-05-08 |
| 2018-09-30 | $748.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.48M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.23M 10-Q · filed 2018-05-10 |
| 2017-09-30 | $765.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.22M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $1.73M 10-Q · filed 2017-06-09 |
| 2016-09-30 | $656.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.18M 10-Q · filed 2016-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |